Purpose
Thrombectomy and intracoronary administration of abciximab via an intracoronary perfusion catheter have been demonstrated to reduce thrombus burden. We analyzed two different treatment strategies: (1) first thrombus-aspiration to reduce thrombus size, then lysis of the rest-thrombus by locally administered abciximab via the ClearWay (CW) RX perfusion catheter versus (2) first pharmacological thrombus-reduction by locally administered abciximab, then, if necessary, thrombus-aspiration of the rest-thrombus.
Methods
This retrospective study included 68 patients who presented with an acute coronary syndrome due to an intracoronary thrombus between May 2009 and April 2011. Thrombus-aspiration first strategy was performed in 39 patients, abciximab first strategy in 29 patients. The primary endpoint was defined as final improvement in Thrombolysis In Myocardial Infarction (TIMI) flow.
Methods
This retrospective study included 68 patients who presented with an acute coronary syndrome due to an intracoronary thrombus between May 2009 and April 2011. Thrombus-aspiration first strategy was performed in 39 patients, abciximab first strategy in 29 patients. The primary endpoint was defined as final improvement in Thrombolysis In Myocardial Infarction (TIMI) flow.
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
